CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-01 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +538,400 | 538,400 | ||
| 2021-12-06 | Brake Rachael Louise Chief Scientific Officer | Grant or award · Stock Option(right to buy) | +500,000 | 500,000 | ||
| 2021-06-17 | Salzmann Peter Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | Salzmann Peter Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | Jenkins John Kenneth Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | Jenkins John Kenneth Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | Jacques Rachelle Suzanne Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | Jacques Rachelle Suzanne Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | HOLMER ALAN F Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | HOLMER ALAN F Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | CATLIN AVERY W Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-06-17 | CATLIN AVERY W Director | Grant or award · Stock Option (right to buy) | +58,200 | 58,200 | ||
| 2021-02-02 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +307,300 | 307,300 | ||
| 2021-02-02 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +307,300 | 307,300 | ||
| 2021-02-02 | Cohen Yuval Chief Executive Officer | Grant or award · Stock Option (right to buy) | +956,500 | 956,500 | ||
| 2021-02-02 | Cohen Yuval Chief Executive Officer | Grant or award · Stock Option (right to buy) | +956,500 | 956,500 | ||
| 2021-02-02 | Millian Craig Stuart Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +307,300 | 307,300 | ||
| 2021-02-02 | Millian Craig Stuart Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +307,300 | 307,300 | ||
| 2021-02-02 | White Barbara Chief Medical Officer | Grant or award · Stock Option (right to buy) | +307,300 | 307,300 | ||
| 2021-02-02 | White Barbara Chief Medical Officer | Grant or award · Stock Option (right to buy) | +307,300 | 307,300 |
Page 11 of 16 · 320 trades